Cravatex Limited

As of June 30, 2026, Cravatex Limited has 2.58M shares outstanding.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 199.96M in revenue per employee across its workforce of 8.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Cravatex Limited recorded 20.03M in income tax expense. That works out to an effective tax rate of 18.88, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 106.07M, leaving 86.04M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Cravatex Limited generated 1.60B in revenue and converted that into 86.04M in net income, yielding earnings per share of 33.27. EBITDA reached -35.58M, while operating income came in at -50.70M.

Over the twelve months ended June 30, 2026, Cravatex Limited posted a gross margin of 50.79, reflecting its pricing power and cost economics. The operating margin of -3.17 and net profit margin of 5.38 provide insight into operational efficiency.

Cravatex Limited's most recent stock split took place on July 15, 2011 with a 1:2 split ratio.